全文获取类型
收费全文 | 1368篇 |
免费 | 87篇 |
国内免费 | 37篇 |
专业分类
耳鼻咽喉 | 14篇 |
儿科学 | 78篇 |
妇产科学 | 20篇 |
基础医学 | 123篇 |
口腔科学 | 30篇 |
临床医学 | 170篇 |
内科学 | 377篇 |
皮肤病学 | 47篇 |
神经病学 | 48篇 |
特种医学 | 200篇 |
外科学 | 71篇 |
综合类 | 30篇 |
预防医学 | 84篇 |
眼科学 | 32篇 |
药学 | 55篇 |
中国医学 | 1篇 |
肿瘤学 | 112篇 |
出版年
2023年 | 6篇 |
2022年 | 13篇 |
2021年 | 30篇 |
2020年 | 15篇 |
2019年 | 15篇 |
2018年 | 31篇 |
2017年 | 18篇 |
2016年 | 20篇 |
2015年 | 38篇 |
2014年 | 24篇 |
2013年 | 56篇 |
2012年 | 66篇 |
2011年 | 59篇 |
2010年 | 61篇 |
2009年 | 62篇 |
2008年 | 43篇 |
2007年 | 47篇 |
2006年 | 38篇 |
2005年 | 58篇 |
2004年 | 45篇 |
2003年 | 23篇 |
2002年 | 49篇 |
2001年 | 27篇 |
2000年 | 25篇 |
1999年 | 25篇 |
1998年 | 54篇 |
1997年 | 57篇 |
1996年 | 53篇 |
1995年 | 37篇 |
1994年 | 43篇 |
1993年 | 35篇 |
1992年 | 18篇 |
1991年 | 23篇 |
1990年 | 13篇 |
1989年 | 27篇 |
1988年 | 46篇 |
1987年 | 23篇 |
1986年 | 23篇 |
1985年 | 32篇 |
1984年 | 10篇 |
1982年 | 6篇 |
1981年 | 9篇 |
1980年 | 9篇 |
1979年 | 14篇 |
1978年 | 9篇 |
1977年 | 12篇 |
1976年 | 12篇 |
1975年 | 5篇 |
1974年 | 6篇 |
1972年 | 5篇 |
排序方式: 共有1492条查询结果,搜索用时 15 毫秒
31.
Results of randomized controlled trials of low-versus high-osmolality contrast media 总被引:1,自引:0,他引:1
The authors reviewed 100 randomized controlled trials (RCTs) conducted in humans to compare safety or efficacy of new low-osmolality contrast media (LOM) with that of high-osmolality contrast media (HOM). Findings of the 43 RCTs judged to be of the highest quality suggest that the efficacy of LOM in imaging is equal or superior to that of HOM for all routes of administration. Heat sensation occurred less often with LOM for all routes and pain occurred less often with LOM for intraarterial routes. No differences were seen in nephrotoxicity or in frequency of nausea, vomiting, urticaria, bronchospasm, laboratory test abnormalities, or neurologic events. Greater cardiovascular changes were seen with HOM, including increased or decreased heart rate, increased left ventricular end-diastolic pressure, decreased systolic pressure, and QT prolongation, depending on route of administration. To demonstrate whether a reduction in clinically significant adverse outcomes truly occurs with LOM, trials will need to enlist larger numbers of patients and employ appropriate outcome measures. Future trials should stratify patients according to their risk of adverse reactions to provide better information about benefits of LOM in low- versus high-risk patients. 相似文献
32.
33.
B-cell acute lymphoblastic leukemia (B-ALL), more frequently than any other B-lineage neoplasm, exhibits oligoclonal Ig heavy chain (IgH) gene rearrangement in 15% to 43% of all cases studied. To study the molecular processes that promote multiple IgH rearrangements, a comprehensive sequence analysis of a B-ALL case was performed in which seven clonal IgH gene rearrangements were identified. The genetic profiles suggested that a single leukemic progenitor clone evolved into several subclones through dual processes of variable (VH) to preexisting diversity-joining (DJH) gene segment rearrangement and VH to VH gene replacement. Predominant IgH-V usage and the uniquely rearranged clonotype-specific VHDJH region gene sequences were identified using a novel DNA-based gene amplification strategy. Polymerase chain reaction (PCR) was directed by an IgH-J generic primer and a complement of family-specific IgH-V primers that defined the major B-cell IgH-V gene usage. Clonality of rearranged VHDJH bands was substantiated by high resolution denaturant gel electrophoretic analysis. Sequence patterns of the amplified VHDJH fragments segregated into two groups defined by common DJH sequences. Partial N region homology at the VHD junction as well as shared DJH sequences firmly established VH to VHDJH gene replacement as a mechanism generating clonal evolution in one group. In the second subset, oligoclonality was propagated by independent VH gene rearrangements to a common DJH precursor. The contributions of all clonal Ig-VHDJH repertoires for each group was approximately 50% and reflected a symmetric distribution of leukemic subclones generated by either process. Thus, oligoclonal rearrangements evolved by two independent, yet seemingly contemporaneous molecular genetic mechanisms. All seven clones displayed nonfunctional Ig-VHDJH recombinations. These observations may have relevance to the recombinatorial opportunities available during normal B-cell maturation. 相似文献
34.
35.
Intra-arterial tissue adhesive for medical splenectomy in humans 总被引:2,自引:0,他引:2
36.
Human cytomegalovirus persists in myeloid progenitors and is passed to the myeloid progeny in a latent form 总被引:9,自引:0,他引:9
Khaiboullina SF Maciejewski JP Crapnell K Spallone PA Dean Stock A Pari GS Zanjani ED Jeor SS 《British journal of haematology》2004,126(3):410-417
CD34+ progenitor cells can harbour latent human cytomegalovirus (HCMV); however, the mechanisms of HCMV latency remain unclear. We have investigated the effects of the haematopoietic lineage restriction on the establishment and spread of the latent HCMV to progeny cells. In vitro-infected and latently-infected haematopoietic progenitor cells derived from HCMV seropositive donors were studied. The presence of HCMV DNA in bone marrow progenitor (BMP) cells was determined by single colony polymerase chain reaction and fluorescent in situ hybridization (FISH). The presence of CMV DNA was found to be restricted to myeloid progenitors and the percentage of HCMV-infected cells was lower in naturally-infected cells than in in vitro-infected cells. Erythroid differentiation resulted in an abortive infection with persistence of the viral nucleic acids in red cell precursors. In BMP cells from HCMV seronegative donors, HCMV DNA was localized in the nucleus. Bone marrow progenitors in the presence of granulocyte-macrophage colony stimulating factor (GMCSF) maintained HCMV DNA for extended periods of time. No viral production could be detected throughout the culture but the comparison of the numbers of latently-infected cells prior to and after the culture suggests that proliferation of haematopoietic progenitor cells may lead to the expansion of latently-infected cells. 相似文献
37.
38.
Infection of hematopoietic progenitor cells by human cytomegalovirus. 总被引:20,自引:2,他引:20
J P Maciejewski E E Bruening R E Donahue E S Mocarski N S Young S C St Jeor 《Blood》1992,80(1):170-178
The susceptibility of hematopoietic progenitor cells to infection by human cytomegalovirus (HCMV) was investigated using several strains of HCMV, including the recombinant strain RC256. RC256 is derived from the laboratory strain Towne and contains the Escherichia coli LacZ gene coding for beta-galactosidase (beta-gal) regulated by an early HCMV promoter. Expression of LacZ allowed the detection of HCMV in individual hematopoietic cells. Clonogeneic bone marrow (BM) progenitors, including CD34+ cells, could be infected with HCMV and would then form normal hematopoietic colonies. By polymerase chain reaction (PCR) amplification of DNA, HCMV could be detected in both erythroid and myeloid colonies. LacZ activity was observed predominantly in cells of myelomonocytic lineage. When cells derived from HCMV-infected progenitors were cocultivated with permissive human fibroblasts, infectious virus expressing LacZ was recovered. Although no characteristic HCMV cytopathology was observed in BM colonies, high virus to cell ratios resulted in a moderate inhibition of colony formation. Since infected hematopoietic progenitors can harbor HCMV for weeks and through several differentiation steps in culture, we postulate that in vivo these cells may serve as a reservoir of latent virus and contribute to HCMV dissemination. 相似文献
39.
Heterogeneous phenotypes of platelet and plasma von Willebrand factor in obligatory heterozygotes for severe von Willebrand disease 总被引:5,自引:0,他引:5
Mannucci PM; Lattuada A; Castaman G; Lombardi R; Colibretti ML; Ciavarella N; Rodeghiero F 《Blood》1989,74(7):2433-2436
To characterize the heterogeneity of severe (type III) von Willebrand disease (vWD), plasma and platelet von Willebrand factor antigen (vWF:Ag) and ristocetin cofactor activity (Ricof) were measured in 28 obligatory heterozygotes (ie, parents or children of probands from 15 different kindreds with severe vWD). On the average, heterozygotes had low levels of vWF in both platelets and plasma. There was, however, considerable heterogeneity, with four distinct patterns. Eleven heterozygotes had concordant reduction of vWF:Ag and Ricof in both plasma and platelets; five had low levels of vWF:Ag and Ricof in plasma contrasting with normal levels in platelets; eight had a peculiar pattern, the reverse of the above (ie, low levels in platelets and normal levels in plasma); and in one, both vWF measurements were normal in plasma and platelets. These patterns were genetically determined: they were consistent in four couples of consanguineous heterozygotes and in two couples carrying the same gene deletion. Only the remaining three heterozygotes had no clearly identifiable pattern. Other findings of this study were that although most of the heterozygotes had normal bleeding times, the 7 of 28 who had prolonged bleeding times had concordantly low levels of vWF measurements in both plasma and platelets. In conclusion, this large series of obligatory heterozygotes provides evidence for phenotypic and genotypic heterogeneity of severe vWD. 相似文献
40.